Drug repositioning is an alternative for the treatment of coronavirus COVID-19

Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different...

Descripción completa

Detalles Bibliográficos
Autores principales: Serafin, Marissa B., Bottega, Angelita, Foletto, Vitória S., da Rosa, Taciéli F., Hörner, Andreas, Hörner, Rosmari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194941/
https://www.ncbi.nlm.nih.gov/pubmed/32278811
http://dx.doi.org/10.1016/j.ijantimicag.2020.105969
_version_ 1783528435547635712
author Serafin, Marissa B.
Bottega, Angelita
Foletto, Vitória S.
da Rosa, Taciéli F.
Hörner, Andreas
Hörner, Rosmari
author_facet Serafin, Marissa B.
Bottega, Angelita
Foletto, Vitória S.
da Rosa, Taciéli F.
Hörner, Andreas
Hörner, Rosmari
author_sort Serafin, Marissa B.
collection PubMed
description Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.
format Online
Article
Text
id pubmed-7194941
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V. and International Society of Chemotherapy.
record_format MEDLINE/PubMed
spelling pubmed-71949412020-05-02 Drug repositioning is an alternative for the treatment of coronavirus COVID-19 Serafin, Marissa B. Bottega, Angelita Foletto, Vitória S. da Rosa, Taciéli F. Hörner, Andreas Hörner, Rosmari Int J Antimicrob Agents Article Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease. Elsevier B.V. and International Society of Chemotherapy. 2020-06 2020-04-09 /pmc/articles/PMC7194941/ /pubmed/32278811 http://dx.doi.org/10.1016/j.ijantimicag.2020.105969 Text en © 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Serafin, Marissa B.
Bottega, Angelita
Foletto, Vitória S.
da Rosa, Taciéli F.
Hörner, Andreas
Hörner, Rosmari
Drug repositioning is an alternative for the treatment of coronavirus COVID-19
title Drug repositioning is an alternative for the treatment of coronavirus COVID-19
title_full Drug repositioning is an alternative for the treatment of coronavirus COVID-19
title_fullStr Drug repositioning is an alternative for the treatment of coronavirus COVID-19
title_full_unstemmed Drug repositioning is an alternative for the treatment of coronavirus COVID-19
title_short Drug repositioning is an alternative for the treatment of coronavirus COVID-19
title_sort drug repositioning is an alternative for the treatment of coronavirus covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194941/
https://www.ncbi.nlm.nih.gov/pubmed/32278811
http://dx.doi.org/10.1016/j.ijantimicag.2020.105969
work_keys_str_mv AT serafinmarissab drugrepositioningisanalternativeforthetreatmentofcoronaviruscovid19
AT bottegaangelita drugrepositioningisanalternativeforthetreatmentofcoronaviruscovid19
AT folettovitorias drugrepositioningisanalternativeforthetreatmentofcoronaviruscovid19
AT darosatacielif drugrepositioningisanalternativeforthetreatmentofcoronaviruscovid19
AT hornerandreas drugrepositioningisanalternativeforthetreatmentofcoronaviruscovid19
AT hornerrosmari drugrepositioningisanalternativeforthetreatmentofcoronaviruscovid19

Ejemplares similares